Regional Citrate Versus Heparin Anticoagulation for Continuous Renal Replacement Therapy: A Meta-Analysis of Randomized Controlled Trials
Author:
Publisher
Elsevier BV
Subject
Nephrology
Reference37 articles.
1. Continuous dialysis is superior to intermittent dialysis in acute kidney injury of the critically ill patient;Ronco;Nat Clin Pract Nephrol,2007
2. A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration;Reeves;Crit Care Med,1999
3. Filter run time in CVVH: pre- versus post-dilution and nadroparin versus regional heparin-protamine anticoagulation;van der Voort;Blood Purif,2005
4. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding;Morabito;J Nephrol,2003
5. Regional filter heparinization for continuous veno-venous hemofiltration in liver transplant recipients;Biancofiore;Minerva Anestesiol,2003
Cited by 158 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nafamostat mesylate versus regional citrate anticoagulation for continuous renal replacement therapy in patients at high risk of bleeding: a retrospective single-center study;European Journal of Medical Research;2024-01-20
2. Solute Clearance Evaluation and Filter Clotting Prediction in Continuous Renal Replacement Therapy;Journal of Clinical Medicine;2023-12-15
3. Alkalosis in Regional Citrate Anticoagulation during Continuous Renal Replacement Therapy—— A single-center retrospective study;2023-10-19
4. Comparison of Citrate and Heparin for Continuous Renal Replacement Therapy in Pediatric Intensive Units;Turkish Journal of Pediatric Emergency and Intensive Care Medicine;2023-10-04
5. Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials;Critical Care;2023-06-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3